General Rheumatology   

Do you generally recommend anti-diarrheals, dietary modifications, or consider this an unacceptable side effect and move to other therapies? 

How has this impacted your counseling and management?

For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?

How do you approach de-escalation or justify therapy maintenance? Do you have tiers of medications that you attempt to de-escalate first? In one parti...

(Patient with active RA despite hydroxychloroquine)

Would the etiology of the thrombocytosis play a role in your decision-making?

When it seems fairly certain that this is a drug effect is it something that can just be monitored or requires a change in approach?